NCT00027391View on ClinicalTrials.gov

Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD)

NACompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

September 30, 2001

Study Completion Date

August 31, 2004

Conditions
Muscular Dystrophies
Interventions
DRUG

Albuterol

DRUG

Oxandrolone

Trial Locations (1)

43210

Ohio State University Medical Center, Columbus

All Listed Sponsors
lead

FDA Office of Orphan Products Development

FED

NCT00027391 - Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD) | Biotech Hunter | Biotech Hunter